tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RARE Stock Latest News

Ultragenyx price target lowered to $57 from $58 at BofA
The FlyUltragenyx price target lowered to $57 from $58 at BofA
3d ago
RARE
Ultragenyx: Better‑Than‑Expected Revenue, Strengthened Liquidity, and Upcoming Pipeline Catalysts Support Maintained Buy Rating
PremiumRatings
Ultragenyx: Better‑Than‑Expected Revenue, Strengthened Liquidity, and Upcoming Pipeline Catalysts Support Maintained Buy Rating
4d ago
RARE
Ultragenyx provides corporate update, catalysts for 2026
PremiumThe Fly
Ultragenyx provides corporate update, catalysts for 2026
4d ago
RARE
Ultragenyx reports preliminary FY25 revenue $672M-$674M, consensus $655.9M
PremiumThe Fly
Ultragenyx reports preliminary FY25 revenue $672M-$674M, consensus $655.9M
4d ago
RARE
Ultragenyx price target lowered to $50 from $55 at Morgan Stanley
PremiumThe Fly
Ultragenyx price target lowered to $50 from $55 at Morgan Stanley
8d ago
RARE
Ultragenyx: Trial Setback Creates Buying Opportunity as Diversified Pipeline and Commercial Base Support $60 Target
PremiumRatingsUltragenyx: Trial Setback Creates Buying Opportunity as Diversified Pipeline and Commercial Base Support $60 Target
11d ago
RARE
Ultragenyx price target lowered to $60 from $80 at H.C. Wainwright
Premium
The Fly
Ultragenyx price target lowered to $60 from $80 at H.C. Wainwright
11d ago
RARE
Ultragenyx price target lowered to $52 from $64 at Guggenheim
Premium
The Fly
Ultragenyx price target lowered to $52 from $64 at Guggenheim
11d ago
RARE
Ultragenyx price target lowered to $58 from $72 at BofA
PremiumThe Fly
Ultragenyx price target lowered to $58 from $72 at BofA
14d ago
RARE
Ultragenyx completes BLA filing for GSDIa gene therapy
PremiumCompany Announcements
Ultragenyx completes BLA filing for GSDIa gene therapy
17d ago
8K
RARE
Ultragenyx completes rolling submission of DTX401 AAV gene therapy BLA to FDA
PremiumThe Fly
Ultragenyx completes rolling submission of DTX401 AAV gene therapy BLA to FDA
17d ago
RARE
Ultragenyx rises 9.7%
PremiumThe Fly
Ultragenyx rises 9.7%
17d ago
RARE
Ultragenyx rises 13.0%
PremiumThe FlyUltragenyx rises 13.0%
17d ago
RARE
DigitalBridge downgraded, Commvault initiated: Wall Street’s top analyst calls
Premium
The Fly
DigitalBridge downgraded, Commvault initiated: Wall Street’s top analyst calls
17d ago
BHP
ERO
Ultragenyx removed from Analyst Focus List at JPMorgan
Premium
The Fly
Ultragenyx removed from Analyst Focus List at JPMorgan
17d ago
RARE
Wells cuts Ultragenyx target, not throwing in the towel yet
PremiumThe Fly
Wells cuts Ultragenyx target, not throwing in the towel yet
17d ago
RARE
Mereo BioPharma downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Mereo BioPharma downgraded to Hold from Buy at Jefferies
18d ago
MREO
RARE
Ultragenyx price target lowered to $63 from $114 at Jefferies
PremiumThe Fly
Ultragenyx price target lowered to $63 from $114 at Jefferies
18d ago
MREO
RARE
Ultragenyx price target lowered to $44 from $50 at Barclays
PremiumThe Fly
Ultragenyx price target lowered to $44 from $50 at Barclays
18d ago
RARE
Ultragenyx: Refocusing on Apazunersen and Strengthened Balance Sheet Support Buy Rating Despite OI Setback
PremiumRatingsUltragenyx: Refocusing on Apazunersen and Strengthened Balance Sheet Support Buy Rating Despite OI Setback
18d ago
RARE
Truist says focus now on Apazunersen after Ultragenyx’s Setrusumab miss
Premium
The Fly
Truist says focus now on Apazunersen after Ultragenyx’s Setrusumab miss
18d ago
RARE
Ultragenyx price target lowered to $50 from $103 at Citi
Premium
The Fly
Ultragenyx price target lowered to $50 from $103 at Citi
18d ago
RARE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >